Skip to content

Replimune

US · REPL #3130 by market cap Listed 2018
19.07 -0.16 -0.83%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
  • Total institutional ownership fell 6.7 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
107.69% -6.74pp
Institutions
229 +1
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund48.14%
Hedge Fund46.08%
Public Company7.45%
VC/PE Fund3.12%
Private Company2.26%
Individual/Insider1.60%
Insurance Company0.39%
Government Pension Fund0.15%

Top holders as of 2026-08-09

Baker Bros. Advisors LP 11.65% · 11.05M sh
BlackRock 9.28% · 8.80M sh
RTW Investments, LP 7.82% · 7.41M sh
Ridgeback Capital Management LLC 7.71% · 7.31M sh
Montanova Capital, LLC 6.97% · 6.61M sh
State Street Global Advisors 4.40% · 4.17M sh
Boxer Capital Management, LLC 4.20% · 3.98M sh
Emerald Advisers, LLC 3.84% · 3.64M sh
Vanguard Capital Management, LLC 3.58% · 3.40M sh
Forbion Capital Partners B.V. 2.98% · 2.81M sh
The Goldman Sachs Group, Inc. 3.10% · 2.94M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 27 buys · 23 sells

NameRoleStake
Baker Bros. Advisors LP -- 11.65%
Philip Astley-Sparke Executive Chairperson 1.35%
Sushil Patel Chief Executive Officer 0.08%
Konstantinos Xynos Chief Medical Officer 0.05%
Emily Hill Chief Financial Officer 0.04%
Christopher Sarchi Former Chief Commercial Officer 0.03%
Kapil Dhingra Independent Director 0.02%
Andrew Schwendenman Chief Accounting Officer & Treasurer 0.02%
Joseph Slattery Independent Director 0.00%
Julian Baker -- --
Michael Goller Independent Director --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-08 Joseph Slattery Independent Director Open Market Disposition -5,200 $21.80
2026-11-02 Paolo Pucci Former Independent Director Intent to Sell (Form 144) -138,700 $20.43
2026-11-01 Kapil Dhingra Independent Director Derivative Exercise and Sale -21,500 $1.75–19.00
2026-11-01 Kapil Dhingra Independent Director Derivative Exercise and Retained +21,669 $1.75
2026-10-29 Veleka Peeples-Dyer Former Independent Director Intent to Sell (Form 144) -10,000 $16.72
2026-10-27 Veleka Peeples-Dyer Former Independent Director Intent to Sell (Form 144) -12,000 $12.90
2026-08-19 Philip Astley-Sparke Executive Chairperson Other Disposition -50,000 --
2026-08-16 Emily Hill Chief Financial Officer Open Market Disposition -9,256 $14.28
2026-08-10 Baker Bros. Advisors LP -- Open Market Derivative Acquisiti +2,736,340 $0.00
2026-08-09 Emily Hill Chief Financial Officer Open Market Disposition -11,448 $12.97
2026-08-09 Sushil Patel Chief Executive Officer Open Market Disposition -39,341 $12.97
2026-08-09 Andrew Schwendenman Chief Accounting Officer & Treasurer Open Market Disposition -7,632 $12.97
2026-08-09 Konstantinos Xynos Chief Medical Officer Open Market Disposition -11,447 $12.97
2026-05-31 Christopher Sarchi Former Chief Commercial Officer Automatic Disposition -12,000 $9.24
2026-05-17 Philip Astley-Sparke Executive Chairperson Open Market Disposition -17,657 $5.08
2026-05-17 Emily Hill Chief Financial Officer Open Market Disposition -7,812 $5.08
2026-05-17 Sushil Patel Chief Executive Officer Open Market Disposition -37,324 $5.08
2026-05-17 Christopher Sarchi Former Chief Commercial Officer Open Market Disposition -8,626 $5.08
2026-05-17 Andrew Schwendenman Chief Accounting Officer & Treasurer Open Market Disposition -7,894 $5.08
2026-05-17 Konstantinos Xynos Chief Medical Officer Open Market Disposition -14,023 $5.08

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:01:05 · For reference only, not investment advice and not tailored to your situation.

Replimune discussion 0 comments

Add a comment